| EACPX | FFAFX | EACPX / FFAFX | |
| Total Expense Ratio | 1.23 | 0.35 | 351% |
| Annual Report Gross Expense Ratio | 1.23 | 0.35 | 351% |
| Fund Existence | 25 years | 5 years | - |
| Gain YTD | 8.639 | 19.205 | 45% |
| Front Load | 5% | N/A | - |
| Min. Initial Investment | 1000 | 250 | 400% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 164M | 339B | 0% |
| Annual Yield % from dividends | 0.00 | 0.54 | - |
| Returns for 1 year | 4.32 | 7.34 | 59% |
| Returns for 3 years | 67.75 | 63.71 | 106% |
| Returns for 5 years | 45.97 | 34.69 | 133% |
| Returns for 10 years | 194.23 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SHSKX | 74.21 | N/A | N/A |
| BlackRock Health Sciences Opps K | |||
| HEQFX | 5.07 | N/A | N/A |
| Monteagle Opportunity Equity Inv | |||
| PDECX | 17.83 | N/A | N/A |
| PGIM Jennison Emerging Markets Eq Opps C | |||
| SSILX | 15.49 | N/A | N/A |
| State Street International Stock Sel A | |||
| MKFOX | 9.36 | N/A | N/A |
| BlackRock Large Cap Focus Growth K | |||